Alterations in Lipid-Lipoprotein Fractions and Antioxidant Status by Lycopene and its Blends with Rice Bran Oil in Nutritionally Induced Hyperlipidemic Animal Model


  • Komal Chauhan Department of Food Science and Technology, National Institute of Food Technology and Entrepreneurship and Management,



Lycopene, Hyperlipidemia, Oxidative Stress, Rice Bran Oil, Antioxidants.


Nutrition Transition in the latter half of 20th century has prompted profound shift from traditional dietary pattern of fibre rich foods to increased consumption of energy dense, high fat and low fibre foods. Resultant oblivious nutritional environment coupled with physical inactivity has abridged the gap between health and chronic diseases. Consequently, the paradigm of treatment from pharmaceuticals has shifted to neutraceuticals and a large proportion of populace is resorting to cost effective treatments from natural sources that can contribute effectually in combating these dreadful diseases. The present study was undertaken to evaluate the efficacy of blends of lycopene and rice bran oil (RBO) on alteration in lipid metabolism and oxidative stress biomarkers in high fat high cholesterol diet fed albino rats. The rats were supplemented with lycopene (30mg/kg/day) singly and blend of lycopene (30mg/kg/day) and rice bran oil (100ml/kg/day) for 6 weeks. Results indicate that lycopene enriched diets significantly (p≤0.05) improved altered parameters, however, the effect was more pronounced in animals reared on blends of lycopene and RBO. The therapeutic potential of lycopene and RBO can be tapped as preventive and protective therapy against the detrimental effects of high fat diets consumed globally.


[1] Sathivel A, Raghavendran HR, Srinivasan P, Devaki T. Anti-peroxidative and anti-hyperlipidemic nature of Ulva lactucacrude polysaccharide on D-galactosamine induced hepatitis in rats. Food Chem Toxicol 2008; 46(10): 3262-3267.
[2] Epstein FM. Age and the cardiovascular system. New Eng J of Med 1992; 327: 173.
[3] WHO. Diet, nutrition and the prevention of chronic diseases. Report of a WHO study group. Geneva, WHO; 2003
[4] Slim RM, Toborek M, Watkins BA, Boissonneault GA, Hennig B. Susceptibility to hepatic oxidative stress in rabbits fed different animal and plant fats. J Am Coll Nutr 1996; 15 (3): 289-294.
[5] Andrej D, Biljana G, Rok D, Petra K, Julijana K. Pharmaceutical nanotechnology nanosized particles of orlistat with enhanced in vitro dissolution rate and lipase inhibition. Int J Pharm 2010; 396: 149-155.
[6] Anila L, Vijayalakshmi NR. Flavonoids from Emblica officinalis and Mangifera indica-effectiveness for dyslipidemia. J of Ethno 2002; 79: 81-87.
[7] Minhajuddin M, Beg ZH, Iqbal J. Hypolipidemic and antioxidant properties of tocotrienol rich fraction isolated from rice bran oil in experimentally induced hyperlipidemic rats. Food Chem Toxicol 2005; 43 (5): 747-753.
[8] Gorinstein S, Leontowicz H, Leontowicz M, Drzewiecki J, Najman K, Katrich E. Raw and boiled garlic enhances plasma antioxidant activity and improves plasma lipid metabolism in cholesterol-fed rats. Life Sci 2006; 78 (6): 655-663.
[9] Harnafi H, Caid HS, Bouanani NH, Aziz M, Amrani S. Hypolipemic activity of polyphenol-rich extracts from Ocimum basilicum in triton WR-1339-induced hyperlipidemic mice. Food Chem 2008; 108: 205-212.
[10] Rao AV, Agarwal S. Role of lycopene as antioxidant carotenoid in the prevention of chronic disease: A review. Nutr Res 1999; 19: 305-323.
[11] Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid. Arch Biochem Biophys 1989; 274: 532.
[12] Cavusoglu K, Oruc E, Yapar K, Yalcin E. Protective effect of lycopene against mercury-induced cytotoxicity in albino mice: Pathological evaluation. J Environ Biol 2009; 30 (5): 807-814.
[13] Kim AY, Jeong YJ, Park YB, Lee MK, Jeon SM, McGregor RA, Choi MS. Dose dependent effects of lycopene enriched tomato-wine on liver and adipose tissue in high-fat diet fed rats. Food Chem 2012; 130 (1): 42-48.
[14] Shi J, Maguer ML, Kakuda Y, Liptay A, Niekamp F. Lycopene degradation and isomerization in tomato dehydration. Food Res Int 1999; 32(1): 15-21.
[15] Ghafoorunssia, Dietary lipids and heart disease- the Indian context. Natl Med J India 1994; 7(6): 270-276.
[16] Seetharamaiah GS, Chandrasekhara N. Studies on hypocholesterolemic activity of rice bran oil. Athero 1989; 78: 219-223.
[17] Rong N, Ausman LM, Nicolosi RJ. Rice bran oil decreases plasma LDL cholesterol by inhibiting dietary cholesterol absorption. FASEB J 1994; 8A162.
[18] Rong N, Ausman LM, Nicolosi RJ. Oryzanol decreases cholesterol absorption and aortic fatty streaks in hamsters. Lipids 1997; 32: 303-309.
[19] Raghuram TC, Rukmini C. Nutritional significance of rice bran oil. Ind J Med Res 1995; 102: 241-244.
[20] Reeves PG, Nielsen FH, Fahey Jr GC. AIN-93 Purified diets for laboratory rodents: Final report of the American institute of nutrition adhoc writing committee on the reformulation of the AIN-76 a rodent diet. J Nutr 1993; 123: 1939-1951.
[21] OECD, Guidelines of testing of chemicals, 423 acute oral toxicity (acute toxic class method).2001.
[22] Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of LDL-C in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
[23] Caraway WT. Standard methods of clinical chemistry, D. Seligson (Eds) New York and London: Academic press; 1963, 4 pp. 239.

[24] Reitman, Frankel. Am. J. Clin. Pathol. 1957; 28: 56-63, In: Haoks Physiological Chemistry. Oser BL (ed), New Delhi: Tata McGraw Hill Publishers; 1979, pp.1125-1127.
[25] Belfield A, Goldberg DM. Colorimetric determination of alkaline phosphatase activity. Enzym 1971; 12: 561-568.
[26] Folch J, Lees M, Stanley GHS. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem 1957; 226: 497-507.
[27] Mosback EH, Klenisky HJ, Hal P, Kendall EE. Determination of deoxycholic acid and cholic acid in bile. Arch Biochem Biophys 1954; 51: 402-409.
[28] Gutteridge JMC. Bleomycin detectable iron in knee joint synovial fluid from arthritic patients and its relationship to extracellular antioxidant activities of ceruloplasmin, transferrin and lactoferrin. Biochem J 1987; 245: 415-421.
[29] Satoh K. Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clinica Chimica Acta 1978; 90: 37-43.
[30] Ellman GL. Tissue sulphydryl groups. Arch Biochem Biophys 1959; 82: 70-77.
[31] Ohkawa H, Oshishi N, Yagi K. Assay of lipid peroxides in animal tissues by thiobarbituric acid reaction. Ann Biochem 1979; 95: 351.
[32] Sedlak J, Lindsey RH. Estimation of total protein bound and non protein sulphydral groups in tissues with ellman’s reagent. Ann Biochem 1968; 25: 192.
[33] Necheles TF, Bolas TA, Allen DM. Erythrocyte glutathione peroxidase deficiency and haemolytic disease of the new born infant. J Paed 1968; 72 (3): 31.
[34] Luck H. Catalase, in: Methods of enzymatic analysis. Berameyer Hansulrich (Eds) , New York, London: Academic Press; 1971; pp. 855.
[35] Kono Y. Generation of superoxide radical during autooxidation of hydroxylamine and an assay for SOD. Arch Biochem Biophy 1978; 186: 189.
[36] Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the folin phenol reagent. J Biol Chem 1951; 193: 265-275.
[37] Korn ED. Lipoprotein lipase (clearing factor). Methods Enzymol 1962; 5: 542-545.
[38] Hitz J, Steinmetz J, Siest G. Plasma lecithin: cholesterol acyl transferase-reference values and effects of xenobiotics. Clin Chim Acta 1983; 133: 85-96.
[39] Kothari HV, Miller BF, Kritchevsky D. Aortic cholesterol esterase: characteristics of normal rat and rabbit enzyme. Biochem Biophys Acta 1973; 296: 446-454.
[40] Schmidt FH, Stork H, Dahl K. Methods in enzymatic analysis, in: H.V. Bergmeyer, (Eds.), New York: Academic Press; 1974, pp. 819.
[41] Rao AV, Ramakrishnan S. Indirect assessment of hydroxymethylglutaryl- Co A reductase (NADPH) activity in liver tissue. Clin Chem 1975; 21: 1523-1525.
[42] Verghese M, Richardson JE, Boateng J, Shackelford LA, Howard C, Walker LT, Chawan CB. Dietary lycopene has a protective effect on cardiovascular disease in New Zealand male rabbits. J Biol Sci 2008; 8: 268-277.
[43] Hu MY, Li YL, Jiang CH, Liu ZQ, Qu SL, Huang YM. Comparison of lycopene and fluvastatin effects on atherosclerosis induced by a high fat diet in rabbits. Nutr 2008; 24: 1030-1038.
[44] Lee LC, Wei L, Huang WC, Hsu YJ, Chen YM, Huang CC. Hypolipidemic effect of tomato juice in hamsters in high cholesterol diet-induced hyperlipidemia. Nutr 2015; 7: 10525-10537.
[45] Sharma RD, Rukmini C. Rice bran oil and hypocholesterolemia in rats. Lipids 1986; 21: 715-717.
[46] Sharma RD, Rukmini C. Hypocholesterolemic activity of unsaponifiable mater of rice bran oil. Ind J Med Res 1987; 85: 278-281.
[47] Seetharamaiah GS, Chandrasekhara N. Studies on hypocholesterolemic activity of rice bran oil. Athero 1989; 78: 219-223.
[48] Seetharamaiah GS, Chandrasekhara N. Effect of oryzanol on cholesterol absorption and biliary and fecal bile acid in rats. Ind J Med Res 1990; 92: 471-475.
[49] Arranz S, Martínez-Huélamo M, Vallverdu-Queralt A, Valderas-Martinez P, Illán M, Sacanella E, Escribano E, Estruch R, Lamuela-Raventos RM. Influence of olive oil on carotenoid absorption from tomato juice and effects on postprandial lipemia. Food Chem 2015; 168: 203-210.
[50] Colle IJ, Lemmens L, Van Buggenhout S, Met K, Van Loey AM, Hendrickx ME. Processing tomato pulp in the presence of lipids: The impact on lycopene bioaccessibility. Food Res Int 2013; 51: 32-38.
[51] Cooperstone JL, Ralston RA, Riedl KM, Haufe TC, Schweiggert RM, King SA, Schwartz SJ. Enhanced bioavailability of lycopene when consumed as cis-isomers from tangerine compared to red tomato juice, a randomized, cross-over clinical trial. Mol Nutr Food Res 2015; 59: 658-669.
[52] Parthasarathy S. High density lipoprotein inhibits the oxidative modification of low density lipoprotein. Biochim Biophys Acta 1990; 1044: 275-283.
[53] Reiner Z, Tedeschi-Reiner E. Atherosclerosis-a paradox of Eastern European countries. Athero 2006; 7(3): 461.
[54] Witztum JL. The oxidation hypothesis of atherosclerosis. Lancet 1994; 344: 793-795.
[55] Terasaka N, Wang N, Charvet LY, Tall AR. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc Natl Acad Sci USA 2007; 104 (38): 15093-15098.
[56] Marsch D, Knowles PF, Rattle H W E. Magnetic Resonance of Biomolecules, New York: John Wiley and Sons; 1976, pp.237.
[57] Narasimhamurthy K, Raina PL, Hariharan K. Effect of long term feeding of high fat diets on growth, plasma and tissue lipids in rats. J Food Sci Technol 1997; 34 (4): 303-310.
[58] Goldberg IJ. Lipoprotein lipase and lipolysis: central roles in lipoprotein metabolism and atherogenesis. J Lipid Res 1996; 37: 693-707.
[59] Sheriff SA, Devaki T. Lycopene stabilizes lipoprotein levels during D-galactosamine/ lipopolysaccharide induced hepatitis

in experimental rats. Asian Pac J Trop Biomed 2012; 2(12): 975-980.
[60] Chauhan K, Chauhan B. Rice bran oil and oryzanol attenuates dyslipidemia and oxidative stress in atherogenic diet fed rats. Int J of Med and Pharm Sci 2015; 5 (4): 53-68.
[61] Martinez LO, Jacquet S, Terce F, Collet X, Perret B, Barbaras R. New insight on the molecular mechanisms of high density lipoprotein cellular interaction. Cell Mol Life Sci 2004; 61: 2343-2360.
[62] Zou YP, Lu YH, Wei DZ. Hypocholesterolemic effects of a flavonoid-rich extract of Hypericum perforatum L. in rats fed a cholesterol-rich diet. J Agric Food Chem 2005; 53: 2462-2466.
[63] Wang Y, Li Y, Sun A, Wang F, Yu G. Hypolipidemic and antioxidative effects of aqueous enzymatic extract from rice bran in rats fed a high-fat and cholesterol diet. Nutr 2014; 6: 3696-3710.
[64] Jonas A. Lecithin-cholesterol acyltransferase in the metabolism of high-density lipoproteins. Biochim Biophys Acta 1991; 1084: 205-220.
[65] Kunnen S, Eck MV. Lecithin:cholesterol acyltransferase: old friend or foe in atherosclerosis? J Lipid Res 2012; 53(9): 1783-1799.
[66] Asztalos BF, Schaefer EJ, Horvath KV, Yamashita S, Miller M, Franceschini G, Calabresi L. Role of LCAT in HDL remodeling: investigation of LCAT deficiency states. J Lipid Res 2007; 48: 592-599.
[67] Jain KS, Kathiravan M K, Somani RS, Shishoo CJ. The biology and chemistry of hyperlipidemia. Bioorg and Med Chem 2007; 15: 4674-4699.
[68] Klein RL, Rudel LL. Cholesterol absorption and transport in thoracic duct lymph lipoproteins of nonhuman primates. Effect of dietary cholesterol level. J of Lipid Res 1983; 24: 343-356.
[69] Rudel LL, Shelness GS. Cholesterol esters and atherosclerosis-a game of ACAT and mouse. Nat Med 2000; 6: 1313-1314.
[70] Upaganlawar AB, Balaraman R. Cardioprotective effect of vitamin E in combination with lycopene on lipid profile, lipid metabolizing enzymes and infarction size in myocardial infarction induced by isoproterenol. Pharmacol 2012; 3(7): 215-220.
[71] Goldstein J L, Brown MS. Regulation of the mevalonate pathway. Nature 1990; 343: 425-430.
[72] Bansal P, Gupta SK, Ojha SK, Nandave M, Mittal R, Kumari S, Arya DS. Cardioprotective effect of lycopene in the experimental model of myocardial ischemia-reperfusion injury. Mol Cell Biochem 2006; 289: 1-9.
[73] Breinholt V, Lauridsen ST, Daneshvar B, Jakobsen J. Dose-response effects of lycopene on selected drug-metabolizing and antioxidant enzymes in the rat. Cancer Lett 2000; 154: 201-210.
[74] Sudhahar V, Kumar S A, Varalakshmi P. Effect of lupeol and lupeol linoleate on lipemic - hepatocellular aberrations in rats fed a high cholesterol diet. Mol Nutr Food Res 2006; 50(12): 1212-1219.
[75] Soliman AM. Potential impact of Paracentrotus lividus extract on diabetic rat models induced by high fat diet/streptozotocin. J Basic and App Zoology 2016; 77: 8-20.
[76] Hull TD, Agarwal A. Bilirubin: a potential biomarker and therapeutic target for diabetic nephropathy. Diab 2014; 63: 2613- 2616.
[77] Nanji AA, Tsukamoto H, French SW. Relationship between fatty liver and subsequent development of necrosis, inflammation and fibrosis in experimental alcoholic liver disease. Exp Mol Pathol 1989; 51(2):141-148.
[78] Gilat T, Leikin-Frenkel A, Goldiner I, .Juhel C, Lafont H, Gobbi D, Konikoff FM. Prevention of diet-induced fatty liver in experimental animals by the oral administration of a fatty acid bile acid conjugate (FABAC). Hepatology 2003; 38: 436-442.
[79] Ahuja KD, Pittaway JK, Ball MJ. Effects of olive oil and tomato lycopene combination on serum lycopene, lipid profile, and lipid oxidation. Nutr 2006; 22: 259-265.

[80] Wilson TA, Nicolosi RJ, Woolfrey B, Kritchevsky D. Rice bran oil and oryzanol reduce plasma lipid and lipoprotein cholesterol concentrations and aortic cholesterol ester accumulation to a greater extent than ferulic acid in hypercholesterolemic hamsters. J Nutr Biochem 2007; 18: 105-112.
[81] Erdman Jr JW, Ford NA, Lindshield BL. Are the health attributes of lycopene related to its antioxidant function? Arch Biochem Biophys 2009; 483: 229-235.
[82] Shakib MC, Gabrial S, Gabrial G. Rice bran oil compared to atorvastatin for treatment of dyslipidemia in patients with type 2 diabetes. J of Med Sci 2014; 15(2): 95-102.
[83] Aidoud A, Ammouche A, Garrido M, Rodriguez AB. Effect of lycopene-enriched olive and argan oils upon lipid serum parameters in wistar rats. J Sci Food Agric 2014; 94(14): 2943-2950.
[84] Maheswari MU, Rao PGM. Antihepatotoxic effect of grape seed oil in rat. Ind J Pharm 2005; 37(3): 179-182.